## Phylogeny  
• Member of the STE kinase group → germinal-centre kinase (GCK) family → GCK III sub-family together with MST4 and STK25 (rak2024developmentofselective pages 4-8).  
• Human MST3 catalytic domain shares ≈90 % sequence identity with MST4 and <20 % with Hippo paralogues MST1/2 (record2010structuralcomparisonof pages 1-3).  
• Canonical sequences display 93 % overall identity between human STK24, mouse Stk24 and rat Stk24 orthologs (qiu2023molecularmechanismsinvolved pages 1-3).  
• Distant orthologous relationship to Saccharomyces cerevisiae Sps1/Ste20 kinases, reflecting an ancestral Ste20 lineage (sugden2013sockmistsmask pages 1-2).  

## Reaction Catalyzed  
ATP + protein-L-Ser/Thr ⇄ ADP + protein-L-Ser/Thr-phosphate (ko2010structuresofhuman pages 1-2).  

## Cofactor Requirements  
• Highest catalytic efficiency with Mn²⁺; Mg²⁺, Zn²⁺ or Co²⁺ can substitute with reduced activity (ko2010structuresofhuman pages 1-2, record2010structuralcomparisonof pages 1-3, sugden2013sockmistsmask pages 16-16).  

## Substrate Specificity  
• Phosphoproteomic profiling assigns a preference for hydrophobic-X-Thr-[Arg/Lys] motifs consistent with the broader STE20 consensus (rak2024developmentofselective pages 4-8).  
• Biochemical mapping defines DW(aHy)F X₀/₃ T* (Hy)(Basic) or (aHy) X₀/₁ T* (Hy)(Basic) where T* is the phospho-acceptor threonine (sugden2013sockmistsmask pages 15-16).  
• Verified cellular substrates include NDR1/2 kinases (sugden2013sockmistsmask pages 15-16) and RhoA Ser26 controlling neuronal migration (qiu2023molecularmechanismsinvolved pages 9-10).  

## Structure  
• Two-domain organisation: N-terminal kinase domain aa 36–286 and C-terminal regulatory tail aa 287–443 containing a bipartite NLS (278–292) and NES (335–386) (qiu2023molecularmechanismsinvolved pages 1-3).  
• Crystal structures resolve active DFG-in conformations with adenine/ADP (PDB 3CKX) and Mn²⁺, revealing Lys53-Glu70 salt bridge, phosphorylated Thr178 in the activation loop, and Asp162 metal coordination (ko2010structuresofhuman pages 1-2).  
• Autophosphorylated structures with diverse inhibitors deposited under PDB 4QML–4QMZ (olesen2016discoveryofdiverse pages 6-8) and selective probes PDB 8BZJ, 8QLR–8QLT (rak2024developmentofselective pages 80-83).  
• Regulatory tail harbours cis-autophosphorylation site Thr328, caspase-3 cleavage motif AETD313, and an N-terminal myristoylation sequence influencing localisation (sugden2013sockmistsmask pages 15-16, qiu2023molecularmechanismsinvolved pages 3-7).  

## Regulation  
Post-translational modifications  
– Thr178 autophosphorylation required for catalytic activation (olesen2016discoveryofdiverse pages 3-4).  
– Thr328 autophosphorylation further enhances activity (sugden2013sockmistsmask pages 15-16).  
– Ser79 phosphorylation by CDK5 modulates neuronal migration signalling (qiu2023molecularmechanismsinvolved pages 3-7).  
– Thr18 phosphorylation on the brain-specific isoform MST3b by PKA augments axon growth (qiu2023molecularmechanismsinvolved pages 3-7).  
– PP2A within the STRIPAK complex dephosphorylates MST3 and restrains signalling (qiu2023molecularmechanismsinvolved pages 3-7, olesen2016discoveryofdiverse pages 3-4).  
– Caspase-3 cleavage at AETD313 yields a nuclear kinase fragment with >10-fold activity increase (wang2011stk24promotesmyogenic pages 28-32).  
– N-terminal myristoylation directs membrane versus nuclear partitioning of the cleaved fragment (qiu2023molecularmechanismsinvolved pages 3-7).  

Allosteric / complex regulation  
• MO25 binding stimulates catalytic output (miller2019comprehensiveprofilingof pages 28-29).  
• STRIPAK assembly suppresses kinase activity via PP2A recruitment (olesen2016discoveryofdiverse pages 1-3).  
• Interaction with CCM3/PDCD10 targets MST3 to Golgi and centrosomes (sugden2013sockmistsmask pages 1-2).  

## Function  
Expression  
• Ubiquitous; highest levels in heart, skeletal muscle, pancreas and developing brain; neuron-restricted isoform MST3b (wang2011stk24promotesmyogenic pages 28-32, sugden2013sockmistsmask pages 2-3, qiu2023molecularmechanismsinvolved pages 1-3, qiu2023molecularmechanismsinvolved pages 9-10).  

Biological roles and partners  
• Mediates oxidative-stress-induced apoptosis by activating JNK1/2 and p38 MAPKs (ko2010structuresofhuman pages 1-2).  
• Controls caspase-independent nuclear death pathway via AIFM1/ENDOG translocation (qiu2023molecularmechanismsinvolved pages 9-10).  
• Promotes radial neuronal migration and optic/radial nerve axon regeneration through RhoA Ser26 phosphorylation (qiu2023molecularmechanismsinvolved pages 9-10, getu2023themammaliansterile pages 3-4).  
• Regulates cell migration through STRIPAK-dependent modulation of paxillin/PTPN12 signalling (olesen2016discoveryofdiverse pages 1-3).  
• Phosphorylates NDR1/2 linking to Hippo-YAP pathway modulation (sugden2013sockmistsmask pages 15-16).  
• Influences epithelial sodium channel activity contributing to hypertension models (qiu2023molecularmechanismsinvolved pages 9-10).  

Upstream modifiers  
CDK5, PKA, PP2A/STRIPAK (qiu2023molecularmechanismsinvolved pages 3-7).  

Downstream substrates  
NDR1/2, RhoA, paxillin/PTPN12 (sugden2013sockmistsmask pages 15-16, qiu2023molecularmechanismsinvolved pages 9-10).  

## Inhibitors  
• Pyrido[2,3-d]pyrimidin-7(8H)-one derivatives MR24, MR26, MR30; cellular IC₅₀ 3–20 nM; co-crystal structures 8BZJ, 8QLR–8QLT; high kinome selectivity in NanoBRET assays (rak2024developmentofselective pages 80-83, rak2024developmentofselective pages 28-33).  
• Broad-spectrum panel of 14 type I inhibitors including staurosporine, bosutinib, danusertib; enzymatic IC₅₀ range 0.003–23 µM; structures 4QML–4QMZ (olesen2016discoveryofdiverse pages 3-4, olesen2016discoveryofdiverse pages 6-8).  

## Other Comments  
• Over-expression correlates with poor prognosis in gastric and breast cancers; knock-down reduces tumour proliferation (getu2023themammaliansterile pages 3-4).  
• Disruption of CCM3 interaction links MST3 to cerebral cavernous malformations (sugden2013sockmistsmask pages 1-2).  
• Functional involvement in ENaC-mediated hypertension provides a cardiovascular disease connection (qiu2023molecularmechanismsinvolved pages 9-10).

References

1. (getu2023themammaliansterile pages 3-4): Ayechew A. Getu, Ming Zhou, Shi-Yuan Cheng, and Ming Tan. The mammalian sterile 20-like kinase 4 (mst4) signaling in tumor progression: implications for therapy. Cancer Letters, 563:216183, Jun 2023. URL: https://doi.org/10.1016/j.canlet.2023.216183, doi:10.1016/j.canlet.2023.216183. This article has 7 citations and is from a peer-reviewed journal.

2. (ko2010structuresofhuman pages 1-2): T. Ko, W. Jeng, Chia-I Liu, M. Lai, Chun-Lan Wu, Wei-Jung Chang, H. Shr, T. Lu, and A. H. Wang. Structures of human mst3 kinase in complex with adenine, adp and mn2+. Acta crystallographica. Section D, Biological crystallography, 66 Pt 2:145-54, Feb 2010. URL: https://doi.org/10.1107/s0907444909047507, doi:10.1107/s0907444909047507. This article has 24 citations.

3. (olesen2016discoveryofdiverse pages 1-3): Sanne H. Olesen, Jin‐Yi Zhu, Mathew P. Martin, and Ernst Schönbrunn. Discovery of diverse small‐molecule inhibitors of mammalian sterile20‐like kinase 3 (mst3). ChemMedChem, Jun 2016. URL: https://doi.org/10.1002/cmdc.201600115, doi:10.1002/cmdc.201600115. This article has 32 citations and is from a peer-reviewed journal.

4. (olesen2016discoveryofdiverse pages 3-4): Sanne H. Olesen, Jin‐Yi Zhu, Mathew P. Martin, and Ernst Schönbrunn. Discovery of diverse small‐molecule inhibitors of mammalian sterile20‐like kinase 3 (mst3). ChemMedChem, Jun 2016. URL: https://doi.org/10.1002/cmdc.201600115, doi:10.1002/cmdc.201600115. This article has 32 citations and is from a peer-reviewed journal.

5. (qiu2023molecularmechanismsinvolved pages 1-3): Jing Qiu, Junzhi Xiong, Lu Jiang, Xinmin Wang, Kebin Zhang, and Hua Yu. Molecular mechanisms involved in regulating protein activity and biological function of mst3. Cell Division, May 2023. URL: https://doi.org/10.1186/s13008-023-00090-x, doi:10.1186/s13008-023-00090-x. This article has 7 citations and is from a peer-reviewed journal.

6. (qiu2023molecularmechanismsinvolved pages 3-7): Jing Qiu, Junzhi Xiong, Lu Jiang, Xinmin Wang, Kebin Zhang, and Hua Yu. Molecular mechanisms involved in regulating protein activity and biological function of mst3. Cell Division, May 2023. URL: https://doi.org/10.1186/s13008-023-00090-x, doi:10.1186/s13008-023-00090-x. This article has 7 citations and is from a peer-reviewed journal.

7. (rak2024developmentofselective pages 4-8): Marcel Rak, Amelie Menge, Roberta Tesch, Lena M. Berger, Dimitrios-Ilias Balourdas, Ekaterina Shevchenko, Andreas Krämer, Lewis Elson, Benedict-Tilman Berger, Ismahan Abdi, Laurenz M. Wahl, Antti Poso, Astrid Kaiser, Thomas Hanke, Thales Kronenberger, Andreas C. Joerger, Susanne Müller, and Stefan Knapp. Development of selective pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-one-based mammalian ste20-like (mst3/4) kinase inhibitors. Journal of Medicinal Chemistry, 67:3813-3842, Feb 2024. URL: https://doi.org/10.1021/acs.jmedchem.3c02217, doi:10.1021/acs.jmedchem.3c02217. This article has 4 citations and is from a highest quality peer-reviewed journal.

8. (rak2024developmentofselective pages 80-83): Marcel Rak, Amelie Menge, Roberta Tesch, Lena M. Berger, Dimitrios-Ilias Balourdas, Ekaterina Shevchenko, Andreas Krämer, Lewis Elson, Benedict-Tilman Berger, Ismahan Abdi, Laurenz M. Wahl, Antti Poso, Astrid Kaiser, Thomas Hanke, Thales Kronenberger, Andreas C. Joerger, Susanne Müller, and Stefan Knapp. Development of selective pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-one-based mammalian ste20-like (mst3/4) kinase inhibitors. Journal of Medicinal Chemistry, 67:3813-3842, Feb 2024. URL: https://doi.org/10.1021/acs.jmedchem.3c02217, doi:10.1021/acs.jmedchem.3c02217. This article has 4 citations and is from a highest quality peer-reviewed journal.

9. (record2010structuralcomparisonof pages 1-3): Christopher J. Record, Apirat Chaikuad, Peter Rellos, Sanjan Das, Ashley C. W. Pike, Oleg Fedorov, Brian D. Marsden, Stefan Knapp, and Wen Hwa Lee. Structural comparison of human mammalian ste20-like kinases. PLoS ONE, 5:e11905, Aug 2010. URL: https://doi.org/10.1371/journal.pone.0011905, doi:10.1371/journal.pone.0011905. This article has 68 citations and is from a peer-reviewed journal.

10. (sugden2013sockmistsmask pages 1-2): P. Sugden, L. McGuffin, and A. Clerk. Sock, mists, mask and sticks: the gckiii (germinal centre kinase iii) kinases and their heterologous protein-protein interactions. The Biochemical journal, 454 1:13-30, Aug 2013. URL: https://doi.org/10.1042/bj20130219, doi:10.1042/bj20130219. This article has 61 citations.

11. (sugden2013sockmistsmask pages 16-16): P. Sugden, L. McGuffin, and A. Clerk. Sock, mists, mask and sticks: the gckiii (germinal centre kinase iii) kinases and their heterologous protein-protein interactions. The Biochemical journal, 454 1:13-30, Aug 2013. URL: https://doi.org/10.1042/bj20130219, doi:10.1042/bj20130219. This article has 61 citations.

12. (wang2011stk24promotesmyogenic pages 28-32): Xi Wang. Stk24 promotes myogenic differentiation via multiple mechanisms. PhD thesis, The Hong Kong University of Science and Technology Library, 2011. URL: https://doi.org/10.14711/thesis-b1155425, doi:10.14711/thesis-b1155425.

13. (olesen2016discoveryofdiverse pages 6-8): Sanne H. Olesen, Jin‐Yi Zhu, Mathew P. Martin, and Ernst Schönbrunn. Discovery of diverse small‐molecule inhibitors of mammalian sterile20‐like kinase 3 (mst3). ChemMedChem, Jun 2016. URL: https://doi.org/10.1002/cmdc.201600115, doi:10.1002/cmdc.201600115. This article has 32 citations and is from a peer-reviewed journal.

14. (qiu2023molecularmechanismsinvolved pages 9-10): Jing Qiu, Junzhi Xiong, Lu Jiang, Xinmin Wang, Kebin Zhang, and Hua Yu. Molecular mechanisms involved in regulating protein activity and biological function of mst3. Cell Division, May 2023. URL: https://doi.org/10.1186/s13008-023-00090-x, doi:10.1186/s13008-023-00090-x. This article has 7 citations and is from a peer-reviewed journal.

15. (sugden2013sockmistsmask pages 15-16): P. Sugden, L. McGuffin, and A. Clerk. Sock, mists, mask and sticks: the gckiii (germinal centre kinase iii) kinases and their heterologous protein-protein interactions. The Biochemical journal, 454 1:13-30, Aug 2013. URL: https://doi.org/10.1042/bj20130219, doi:10.1042/bj20130219. This article has 61 citations.

16. (sugden2013sockmistsmask pages 2-3): P. Sugden, L. McGuffin, and A. Clerk. Sock, mists, mask and sticks: the gckiii (germinal centre kinase iii) kinases and their heterologous protein-protein interactions. The Biochemical journal, 454 1:13-30, Aug 2013. URL: https://doi.org/10.1042/bj20130219, doi:10.1042/bj20130219. This article has 61 citations.

17. (miller2019comprehensiveprofilingof pages 28-29): Chad J. Miller, Hua Jane Lou, Craig Simpson, Bert van de Kooij, Byung Hak Ha, Oriana S. Fisher, Natasha L. Pirman, Titus J. Boggon, Jesse Rinehart, Michael B. Yaffe, Rune Linding, and Benjamin E. Turk. Comprehensive profiling of the ste20 kinase family defines features essential for selective substrate targeting and signaling output. PLOS Biology, 17:e2006540, Mar 2019. URL: https://doi.org/10.1371/journal.pbio.2006540, doi:10.1371/journal.pbio.2006540. This article has 52 citations and is from a highest quality peer-reviewed journal.

18. (rak2024developmentofselective pages 28-33): Marcel Rak, Amelie Menge, Roberta Tesch, Lena M. Berger, Dimitrios-Ilias Balourdas, Ekaterina Shevchenko, Andreas Krämer, Lewis Elson, Benedict-Tilman Berger, Ismahan Abdi, Laurenz M. Wahl, Antti Poso, Astrid Kaiser, Thomas Hanke, Thales Kronenberger, Andreas C. Joerger, Susanne Müller, and Stefan Knapp. Development of selective pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-one-based mammalian ste20-like (mst3/4) kinase inhibitors. Journal of Medicinal Chemistry, 67:3813-3842, Feb 2024. URL: https://doi.org/10.1021/acs.jmedchem.3c02217, doi:10.1021/acs.jmedchem.3c02217. This article has 4 citations and is from a highest quality peer-reviewed journal.
